Supply Chain Has Stabilized. Margins Are Going to Pressure Again.

Supply Chain Has Stabilized. Margins Are Going to Pressure Again.

dental supply shortages that plagued 2021-2023 are over. Patterson, Henry Schein, and Benco all report normalized inventory levels. No more three-week waits for composite or burs. Orders arrive in 3-5 days.

That sounds like good news. It's not. Normalized supply means competitive pricing. When supply is tight, vendors have margin power. When supply is abundant, dentists have margin power. Guess which we have now.

Expect your supply costs to hold flat or decline slightly through 2025. That's good. The catch: Your volume discount expectations will increase. Vendors will push tiered pricing. Patterson will offer you a deal if you consolidate spend. Henry Schein will call with better terms if you move more volume to them.

The competitive pressure on supplies eases. The competitive pressure on services gets fiercer because everyone has access to the same equipment and materials at similar costs.

This is actually good for well-run independents. You can't compete on supply cost against DSOs. You compete on execution and patient experience. When everyone can get burs and composite in five days, your only differentiator is your team and your cases.

Leverage it.

Here's what the normalized supply environment means tactically:

Your supply reps are now incentivized on volume growth, not allocation management. From 2021-2023, their job was rationing scarce inventory. Now their job is hitting sales targets. That shifts negotiating leverage back to you.

Volume tiering is back. Patterson's 2025 pricing structure offers 3% discount at $50K annual spend, 5% at $100K, 7% at $200K. Henry Schein matches it. Benco undercuts both by half a point at each tier. If you're a solo practice doing $35K annual supply spend, you're paying list price. If you're a 4-doctor group doing $180K, you're getting 5-7% off automatically.

The math matters. A solo practice running $800K production typically spends 5-6% on supplies ($40K-$48K annually). A 1% discount saves $400-$480. A 5% discount saves $2,000-$2,400. That's not transformative, but it's also not nothing.

What changes for independents: You can't match DSO buying power (they're negotiating 12-15% discounts at $5M+ annual volume). But you can match their execution if you're disciplined about supply management.

DSOs optimize supply spend through three mechanisms: (1) formulary compliance (every practice uses the same composite, same gloves, same burs - no variation), (2) just-in-time inventory (they order weekly based on actual consumption, not monthly bulk orders), (3) waste tracking (if a practice's supply cost per procedure is 8% and the DSO average is 6%, that practice gets audited).

Independent practices do the opposite. Every doctor picks their own composite. You order monthly and warehouse 6-8 weeks of inventory. You have no idea what your supply cost per procedure actually is because you've never measured it.

The opportunity: Run your supply spend like a DSO without becoming one. Pick a standard formulary (one composite system, one bonding agent, one glove brand). Order weekly based on actual consumption. Track supply cost per procedure monthly (your PM system can generate this if you code supplies correctly). Audit variances.

One 3-doctor practice in Colorado implemented DSO-style supply management in 2024. They dropped supply spend from 6.2% of revenue to 4.8% over 12 months. That's a 1.4-point improvement. On $2.1M revenue, that's $29,400 annual savings. They didn't switch vendors. They didn't negotiate harder. They just stopped wasting supplies and ordered smarter.

OPERATOR MATH

Let's model the margin impact for a 4-doctor general practice doing $3.2M annual production:

Current state (unoptimized supply management):

• Annual production: $3,200,000
• Supply cost as % of production: 6.5%
• Annual supply spend: $208,000
• Current vendor discount: 3% (below volume threshold)
• Net supply cost: $208,000 × 0.97 = $201,760

Future state (optimized, DSO-style management):

• Formulary compliance reduces waste: 6.5% → 5.2%
• New annual supply spend: $3,200,000 × 0.052 = $166,400
• Consolidated vendor volume pushes to 7% discount tier
• Net supply cost: $166,400 × 0.93 = $154,752

Annual savings: $201,760 - $154,752 = $47,008

Implementation cost:

• Formulary development (4 hours PM time × $85/hour): $340
• Staff training on new ordering process (6 hours × $28/hour): $168
• Inventory audit and cleanup (12 hours × $28/hour): $336
• Total: $844

ROI: $47,008 ÷ $844 = 55.7:1 return
Payback period: 6.5 days

Five-year cumulative savings: $47,008 × 5 = $235,040

That's $235K saved over five years from better supply management alone. No revenue growth required. No new patients. Just less waste and smarter ordering.

What kills this for most practices: Doctor preferences. Dr. Smith loves Tetric EvoCeram. Dr. Jones swears by Filtek Supreme. Dr. Lee wants Harmonize. You're now stocking three composite systems, each with 8-10 shades, plus bonding agents for each system. Your inventory cost doubles and you get no volume discount because spend is fragmented across three SKUs.

DSOs solve this by mandating formulary compliance. Independent practices can't mandate (doctors are owners/partners), but you can measure and share the cost. Show Dr. Smith that his composite preference costs the practice $340/month more than the standard formulary. Let him decide if that's worth it. Most doctors don't realize their preferences have a price tag. When you show them the number, 70% voluntarily switch to save the practice money.

THE TAKEAWAY

Action plan for supply cost optimization:

Month 1, Week 1: Pull your supply spend by vendor and by SKU for the last 12 months. Most vendors can export this from your account portal. Calculate supply cost as a percentage of production. If you're above 6%, you have a waste problem. If you're above 7%, you have a serious waste problem.

Month 1, Week 2-3: Conduct an inventory audit. What's sitting on your shelves? How much of it is expired or rarely used? One practice found $8,400 in expired composite and bonding agents that had been sitting unused for 18+ months. That's cash you spent that generated zero revenue.

Month 1, Week 4: Develop a standard formulary. Pick one composite system, one bonding system, one glove brand, one anesthetic. Get doctor buy-in by showing the cost impact of fragmentation. Frame it as "we're optimizing spend to improve margins" not "you have to use what we tell you."

Month 2: Consolidate to one primary vendor (Patterson, Schein, or Benco). Negotiate your discount tier based on projected annual volume. Most reps will give you the next tier up if you commit to 80%+ spend consolidation. Move to weekly ordering based on actual consumption instead of monthly bulk orders.

Month 3: Implement waste tracking. Code every supply item used per procedure in your PM system (most systems support this but practices don't use it). After 30 days, run a report: supply cost per crown prep, per composite, per endo, per extraction. Compare across doctors. High-variance procedures get reviewed.

Month 4: Review the data with your doctors. "Dr. Lee, your supply cost per crown prep is $43. Practice average is $34. What's different about your workflow?" Often it's something simple (over-ordering impression material, not re-using burs appropriately, using premium materials where standard would work). Fix the outliers.

Ongoing (quarterly): Review supply cost % and vendor discount tier. Adjust ordering patterns based on consumption data. Audit expired inventory monthly and stop over-ordering low-turnover items.

Supply chain normalization is an opportunity disguised as a commodity market. DSOs will use it ruthlessly. Independent practices can match their efficiency without sacrificing autonomy - but only if you treat supply management as a profit center, not an afterthought.